|
Volumn 2, Issue , 2000, Pages 83-102
|
Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
DRUG ANTAGONISM;
HUMAN;
IMMUNOLOGY;
MULTIMODALITY CANCER THERAPY;
REVIEW;
RHEUMATOID ARTHRITIS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
COMBINED MODALITY THERAPY;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
EID: 0034584226
PISSN: 14222132
EISSN: None
Source Type: Journal
DOI: 10.1159/000060499 Document Type: Review |
Times cited : (13)
|
References (82)
|